Matterhorn Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-83,171
Closed -$6.96M 52
2015
Q3
$6.96M Sell
83,171
-497
-0.6% -$42K 3.35% 1
2015
Q2
$6.99M Sell
83,668
-5,367
-6% -$409K 2.98% 3
2015
Q1
$6.47M Buy
89,035
+21
+0% +$1.5K 2.89% 4
2014
Q4
$6.14M Sell
89,014
-3,014
-3% -$203K 2.88% 7
2014
Q3
$5.97M Buy
92,028
+14
+0% +$886 2.67% 5
2014
Q2
$5.72M Buy
92,014
+2,329
+3% +$139K 2.54% 10
2014
Q1
$5.17M Sell
89,685
-1,322
-1% -$73.8K 2.39% 9
2013
Q4
$4.64M Buy
91,007
+602
+0.7% +$30.1K 2.14% 16
2013
Q3
$4.55M Buy
90,405
+405
+0.5% +$21.2K 2.28% 15
2013
Q2
$4.42M Buy
+90,000
New +$4.9M 2.44% 15

Other funds holding LLY

Matterhorn Capital Management's LLY Position: Q4 2015 in Review

Matterhorn Capital Management sold out of Eli Lilly (LLY) in Q4 2015, closing a stake of 83,171 shares — an estimated $6.96M sold.

Matterhorn Capital Management first reported a position in LLY in Q2 2013 and held it in 10 quarters. The position peaked at $6.99M in Q2 2015. 1,220 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

  • Matterhorn Capital Management reported no remaining Eli Lilly position as of Q4 2015 after selling out during the quarter.
  • Matterhorn Capital Management sold 83,171 Eli Lilly shares in Q4 2015, an estimated $6.96M.
  • Matterhorn Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 10 quarters.
  • Matterhorn Capital Management's Eli Lilly position peaked at $6.99M in Q2 2015.
  • 1,220 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Matterhorn Capital Management's 13F filing for Q4 2015, filed 2 Feb 2016.